Neguse, Wasserman Schultz Lead Entire Democratic Caucus in Demanding CMS Reverse Course on Rule Threatening Medicaid Access for Cancer Patients

Source: United States House of Representatives – Representative Debbie Wasserman Schultz (FL-23)

“We write to express our profound concern regarding the Centers for Medicare and Medicaid Services’ (CMS) interim final rule titled ‘Medicaid Community Engagement Requirement for Certain Individuals.’ This interim rule will create an undue burden for beneficiaries with serious health care needs and put people at risk of losing coverage, while also creating significant implementation challenges for states. Therefore, we urge CMS to revise this rule, and until such changes are made, call on CMS to authorize states to delay implementation,” wrote the lawmakers.

Washington, D.C. — Today, Representatives Joe Neguse and Debbie Wasserman-Schultz led the entire House Democratic Caucus in a letter to the Centers for Medicare and Medicaid Services (CMS), urging the agency reverse course on a new rule requiring certain Medicaid applicants and enrollees to meet conditions of eligibility in order to access critical healthcare services. The framework implements work requirements mandated by the so-called One Big Beautiful Bill Act (H.R. 1), and has the potential to lock American families facing some of the most dire health conditions out of lifesaving care.

Neguse and Wasserman-Schultz, who have each been impacted by cancer as a caregiver and patient, respectively, also called on CMS to establish, at a minimum, automatic exemptions for patients with cancer and other aggressive illnesses.

“We write to express our profound concern regarding the Centers for Medicare and Medicaid Services’ (CMS) interim final rule titled ‘Medicaid Community Engagement Requirement for Certain Individuals.’ This interim rule will create an undue burden for beneficiaries with serious health care needs and put people at risk of losing coverage, while also creating significant implementation challenges for states. Therefore, we urge CMS to revise this rule, and until such changes are made, call on CMS to authorize states to delay implementation,” wrote the lawmakers. 

More specifically, CMS’s new rule makes it harder for cancer patients and survivors to qualify for Medicaid’s “medical frailty” exemption—stating that a medical condition must significantly impair a person’s ability to comply with the 80-hour per month work requirement. In their letter, the lawmakers argue this framework does not adequately consider the complex nature of illnesses like cancer, which can exhibit periodic or intermittent symptoms often relating to side effects of treatment or the disease itself.

The requirement also forces individuals to prove they can’t work, in an exhaustive process that increases barriers between struggling Americans and access to basic healthcare. 

“Forcing vulnerable patients to exhaustively document their symptoms simply to maintain access to basic healthcare is both imprudent and inconsistent with Federal law. Diagnoses such as an aggressive cancer require patients to receive care as soon as possible, and as you know, any delays to treatment put patients at heightened risk. These and other rapidly progressing conditions become significantly less amenable to treatment in their later stages, meaning a patient’s current capacity to work does not reflect the urgency of their medical needs.”

The House Democratic Caucus, led by Neguse and Wasserman-Schultz, also called attention to the fact that this rule will create significant administrative and financial burdens for states. It departs from a previous definition and requires a rushed change in implementation plans.

They closed by stating that the rule goes even further than Congressional Republicans intended in their disastrous One Big Beautiful Bill Act, which already strips health care coverage from at least 17 million Americans while driving up health care costs for millions more.

The letter concluded: “While there is no way to prevent some eligible people from losing coverage due to the flawed nature of the underlying policy, which in and of itself exacts draconian cuts to healthcare programs and strips access to affordable care for millions of Americans, CMS has an obligation to implement the law in question as written. And, as noted, the new rule appears to be inconsistent with the plain language of H.R. 1, adding a new, restrictive standard that will add to the number of people losing coverage. Indeed, the evidence clearly demonstrates that creating more documentation requirements and adding complexity to the enrollment process will have a devastating effect. Therefore, in sum, we urge CMS to reconsider its interim rule to protect people with serious medical needs. CMS should also delay implementation of the new work requirements pending these changes.”

Read the full letter HERE.

###

Brownley, New Dem Colleagues Call on Trump Administration to Retain USMCA

Source: United States House of Representatives – Julia Brownley (D-CA)

Washington, DC – Today, Congresswoman Julia Brownley (CA-26) joined New Dem Trade and Tariffs Task Force Chair Rep. Don Beyer (VA-08), Global Competitiveness Task Force Chair Rep. Greg Stanton (AZ-04), and 26 New Dem colleagues in a letter to U.S. Trade Representative Jamieson Greer calling on him to retain and, if possible, strengthen the United States-Mexico-Canada Agreement (USMCA), warning that prolonged uncertainty over the agreement threatens American jobs, hurts workers, raises costs for families, and undermines North American competitiveness. This follows the administration’s decision not to extend the agreement on July 1.

USMCA supports roughly 13 million American jobs and nearly $2 trillion in annual trilateral trade, serving as the backbone of integrated North American supply chains in agriculture, manufacturing, and the automotive sector. Allowing uncertainty surrounding the agreement to persist will discourage long-term investment, weaken U.S. competitiveness, and ultimately increase prices on everyday goods for American consumers already struggling with high costs.

The letter reads in part:

“USMCA is a cornerstone of North American competitiveness, American agriculture, and an essential tool for cross-border cooperation. The more the renewal negotiations drag on, the more uncertainty compounds across supply chains and puts at risk the 13 million American jobs and $2 trillion in trilateral trade this agreement supports. While there are important issues that need to be addressed, the core agreement must be retained to enable American workers, businesses, and communities to continue to prosper in the future.”

Through the Coalition’s Governing Agenda, New Dems have championed policies that strengthen domestic manufacturing, reinforce resilient supply chains, expand trade with trusted allies, with the goal of  lowering costs for working families. At a time when businesses need certainty to invest and grow, New Dems are urging the Administration to move quickly to preserve the foundation of North American trade while working collaboratively with Canada and Mexico to modernize the agreement, address outstanding labor and trade concerns, and ensure countries like China cannot exploit loopholes in the North American market.

This letter comes after New Democrat Coalition members penned a letter to Ambassador Greer in November 2025 calling on negotiators to “update and expand the existing framework without undermining the successes and essential components” that have benefited all parties of the agreement.

The full letter can be found here, and below:


Dear Ambassador Greer,

Following the Administration’s decision not to renew the United States-Mexico-Canada Agreement (USMCA) for another 16 years, we write to express our strong support for retaining and enhancing, not exiting, the existing agreement. USMCA is a cornerstone of North American competitiveness, American agriculture, and an essential tool for cross-border cooperation. The more the renewal negotiations drag on, the more uncertainty compounds across supply chains and puts at risk the 13 million American jobs and $2 trillion in trilateral trade this agreement supports. While there are important issues that need to be addressed, the core agreement must be retained to enable American workers, businesses, and communities to continue to prosper in the future.

The decision not to extend USMCA has profound consequences for American businesses and consumers, creating the kind of uncertainty that discourages investment, unnecessarily complicates supply chains, and decreases U.S. competitiveness. Most supply chains require thirty-year lead times to be built, not just five, especially in manufacturing industries where factories can take years to become operational. The longer the negotiations drag on, the more uncertainty will result, and there will be fewer incentives to invest. A destabilized USMCA would ripple through the entire economy and weigh on growth and employment in every sector. Leaving USMCA will result in job losses in any industry dependent on trade with Mexico and Canada, including the agricultural, automobile, and advanced manufacturing sectors. Over time, the supply chain disruptions and the absence of tariff-free trade will raise costs for consumers whose cars, groceries, and other household goods depend on tightly interconnected production networks. Affordability has become a central concern for our constituents. Creating more frictions between Mexico, Canada, and the U.S. is going to make things more expensive here at home. Therefore, what might have seemed like an inconsequential deadline will likely result in profound economic impacts for decades to come.

With these consequences in mind, we urge you to use this review process to quickly reach a consensus with Mexico and Canada to strengthen the agreement and address key outstanding issues. These include our Section 232 “national security” tariffs, which were imposed without congressional oversight or efforts to coordinate with our neighbors. Additionally, any revisions to rules of origin and regional value content should be carefully calibrated to ensure that the continent remains an attractive destination for investment while also ensuring that labor concerns are addressed. Further, we should work with our trading partners to prevent any country, particularly China, from getting a duty-free back door into the North American market.

Finally, the U.S. relationship with Canada and Mexico goes beyond trade. President Trump has repeatedly threatened to annex Canada and turn it into the 51st U.S. state, as well as threatened to bomb targets in Mexico. At this precarious moment for cross-border relations, it is more important than ever that we renew confidence in our North American partnerships. That starts with quickly reaching an agreement to retain and, if possible, enhance the USMCA. We look forward to your prompt response as talks continue with Mexico and Canada in the coming weeks and months.

###

Issues: , ,

Carter bill reducing unnecessary animal testing passes House

Source: United States House of Representatives – Congressman Earl L Buddy Carter (GA-01)

Headline: Carter bill reducing unnecessary animal testing passes House

WASHINGTON, D.C. – Rep. Earl L. “Buddy” Carter (R-GA) today celebrated the House passage of the FDA Modernization Act 3.0, a bill directing the U.S. Food and Drug Administration (FDA) to fully implement provisions to reduce unnecessary animal testing for drug development. 

Each year in the United States, millions of animals – including an estimated 50,000 dogs – are used in laboratory experiments and testing. This bill would require the FDA to fully implement the FDA Modernization Act 2.0, ensuring that safe and effective treatments are developed using advanced, innovative non-animal testing methods when possible. 

“The House passage of the FDA Modernization Act 3.0 marks a major step toward a more modern, effective, and humane system for evaluating medicines,” said Rep. Carter. “My bill will help update testing practices to reduce unnecessary animal harm, remove barriers to innovative, safe, and effective non-animal testing methods, and ensure the FDA’s implementation fully reflects both the law and today’s scientific capabilities.”

“Patients deserve access to the most advanced medical technology available. The FDA Modernization Act 3.0 ensures that drug testing reflects today’s innovations, helping to bring promising healthcare to families faster without compromising safety through unnecessary reliance on animal testing,” said Rep. Vern Buchanan (R-FL). “As the Health Subcommittee Chairman of Ways and Means and the champion of the FDA Modernization Act 2.0, I am proud to see my bill’s impact be reinforced by this critical piece of legislation.”

“This bill will transform drug development for the 21st century. By requiring full implementation of the FDA Modernization Act 3.0, this legislation ensures that developers use innovative, more effective testing methods throughout drug development, rather than relying on outdated and inhumane animal tests. It’s a win for patients, a win for innovation, and a win for animal welfare. I’m proud to champion this bipartisan measure to accelerate safer, more humane, and more effective medical breakthroughs,” said Rep. Troy A. Carter, Sr. (D-LA).

“Today’s floor vote is another important step toward modernizing how we bring safe and effective drugs to market,” said Rep. Diana Harshbarger (R-TN). “The FDA has the authority to move beyond outdated, cruel testing methods, and our bill simply directs the FDA to follow through and update its regulations accordingly. I’m proud to work alongside Congressman Buddy Carter and my colleagues to keep this bipartisan effort moving forward.”

“Four years ago, many people believed eliminating the archaic animal testing mandate in federal law was impossible. Today, Congress is completing that work, thanks in considerable part to the incredible leadership of Congressman Buddy Carter,” said Wayne Pacelle, President, Center for a Humane Economy, Animal Wellness Action. “FDA Modernization Act 3.0 will help us fix a broken drug development system and stop putting dogs and primates through needless torment.”

Read bill text here.

###

WATCH: CARTER SPEAKS OUT AGAINST UNNECESSARY ANIMAL TESTING

Source: United States House of Representatives – Congressman Earl L Buddy Carter (GA-01)

Headline: WATCH: CARTER SPEAKS OUT AGAINST UNNECESSARY ANIMAL TESTING

WASHINGTON, D.C. – Rep. Earl L. “Buddy” Carter (R-GA) today spoke on the House Floor in support of his bill, the FDA Modernization Act 3.0. This bipartisan legislation would bring the Food and Drug Administration’s (FDA) regulations into the 21st century by recognizing modern, safe, and effective alternatives to traditional animal testing when possible.

The bill requires the FDA to update outdated regulations to reflect current law, providing researchers with greater flexibility to use innovative nonclinical testing methods without compromising the agency’s gold standard for drug safety and effectiveness.

Watch Rep. Carter’s floor remarks here:

“Mr. Speaker, I rise today in strong support of my bill, H.R. 2821, the FDA Modernization Act 3.0, bipartisan legislation that ensures the FDA fully embraces modern science while reducing unnecessary animal testing.

Many of our families would feel incomplete without the pets and animals that bring unconditional love into our lives.

Yet every year, millions of animals, including dogs, man’s best friend, are still subjected to testing in the development of new medicines.

As policymakers, we have a responsibility to protect those who cannot protect themselves.

That responsibility includes embracing scientific innovation that can reduce unnecessary animal suffering while continuing to deliver safe and effective treatments to patients.
 

In 2022, Congress took an important first step by passing the FDA Modernization Act 2.0.

I was proud to help lead that effort.

That law gave drug developers the ability to use modern, scientifically validated alternatives to traditional animal testing when appropriate.

Congress made its intent clear.

We wanted to encourage more effective, more humane, and more innovative approaches to drug development.
 

Unfortunately, the previous administration failed to fully implement the law.

Without clear implementation, too many researchers have lacked the certainty they need, and too many animals continue to be used in testing that modern science can increasingly replace.

H.R. 2821 ensures the FDA finally carries out the will of Congress.

This bill is not about lowering standards. It is about raising them.

Today’s researchers have access to technologies that simply did not exist a generation ago.

Advanced human cell models. Organ-on-a-chip technology. Artificial intelligence and computational modeling.

These innovative tools have the potential to better predict how medicines will perform in humans while reducing reliance on animal testing.

Our laws should reflect the science of today, not the science of decades past.

Modernizing drug development doesn’t just benefit animals. It benefits patients.

By providing greater clarity and encouraging the use of validated alternative methods, we can help make the drug development process more efficient.

That means fewer unnecessary delays and more innovation.
 

And ultimately, that means lifesaving treatments can reach patients more quickly without compromising the FDA’s rigorous standards for safety and effectiveness.

This is a commonsense, bipartisan bill. It reflects a simple principle.

We can advance medical innovation while improving animal welfare.

Those goals are not in conflict. In fact, they go hand in hand.
 

Mr. Speaker, the FDA Modernization Act 3.0 fulfills the promise Congress made when we passed FDA Modernization Act 2.0.

It ensures that modern science is fully incorporated into our regulatory process.

It helps reduce unnecessary animal testing and strengthens American medical innovation.

And it helps bring new therapies to patients more efficiently.

I urge my colleagues to support H.R. 2821, the FDA Modernization Act 3.0.”

###

Amata: My Opposition to Seabed Mining Is Unchanged

Source: United States House of Representatives – Congresswoman Aumua Amata (Western Samoa)

Washington, D.C. – Congresswoman Uifa’atali Amata is stating clearly that her position against seabed mining in waters surrounding American Samoa has not changed and remains her consistent position. Amata further notes that no one else speaks for her, despite characterizations and assumptions of her position, whether Republicans or Democrats. 

“This is my seventh public statement on this issue, because of its importance, and because various posts, comments, or statements sometimes say they describe my position – they do not. I was clear from the beginning, first that I stand with the people and then with further statements of opposition as we learned more. I submitted opposition comments to the Interior Department, and in the congressional record speaking out at congressional committee hearings. I remain opposed and consistent,” said Congresswoman Amata. 

“In this position, I am confident that I represent a majority of our people on this, which is the job of the House representative. In fact, the founders of the United States purposely designed the House of Representatives through the Constitution to be the people’s house and most directly represent the will of the people, more so than any other aspect of the federal government,” Amata concluded. “I take that responsibility seriously. I represent our people, and most of our people are opposed.”

###

Davids Secures $34 Million Federal Investment to Grow Kansas City's Biomanufacturing Industry, Create Good-Paying Jobs

Source: United States House of Representatives – Congresswoman Sharice Davids (KS-3)

Today, Representative Sharice Davids announced that the U.S. Economic Development Administration (EDA) has awarded $33.5 million to the Kansas City BioSecure Manufacturing Tech Hub (KC BioHub). The major grant will help expand the region’s leadership in biomanufacturing, strengthen domestic supply chains for lifesaving medicines, and create good-paying jobs. The Tech Hubs program and this funding was created through the bipartisan CHIPS and Science Act, which Davids voted to pass.

“This is a huge win for Kansas City,” said Davids. “Our region has everything it takes to lead the future of medical innovation, and this investment is proof that the rest of the country sees that, too. It will help create good-paying jobs, strengthen our regional economy, and reinforce America’s supply chains and national security. I’m proud to have helped make this possible, and I’ll keep fighting to bring more opportunities like this home to Kansas.”

“This award is a vote of confidence in the strength of our regional assets, the depth of our relationships with our partners, and the promise of our shared vision for the future,” said Melissa Roberts Chapman, President & Regional Innovation Officer, KC BioHub. “Together, we have demonstrated that our region has the talent, infrastructure, partnerships, and innovation necessary to onshore the manufacturing of biologics. As a consortium, we have positioned the Kansas City region to lead in the global race to build the next great biotech ecosystem.”

The award marks the latest milestone for the KC BioHub. In 2023, the Kansas City region was selected as one of only 31 inaugural Tech Hubs nationwide because of its unique strengths in biotechnology and biomanufacturing. In 2024, after narrowly missing out on the first round of implementation funding, the consortium received a $500,000 award to continue developing projects and preparing for future investment. Today’s announcement builds on that progress by providing approximately $34 million to help bring the region’s vision to life.

Led by BioNexus KC, the KC BioHub brings together businesses, research universities, hospitals, entrepreneurs, workforce partners, and state and local governments to position the region as a global leader in biomanufacturing. The consortium focuses on developing and manufacturing biologic medicines and cancer therapies, strengthening domestic production of critical medical technologies, and helping new biotechnology companies grow and commercialize their discoveries more quickly. The investment is expected to accelerate innovation, attract additional private investment, and support the growth of a highly skilled workforce in the region.

Davids has long championed federal investments that strengthen the Kansas economy and create opportunities for workers. She voted for the bipartisanCHIPS and Science Act, which established the Tech Hub program to ensure that the technologies of the future are developed and manufactured in the United States. Davids urged the administration multiple times to grant this designation and led a discussion with senior Department of Commerce officials, local leaders, manufacturers, and researchers to discuss implementation of the bill, including Kansas City’s Tech Hub designation.

Since the Kansas City region was first designated as a Tech Hub, Davids has worked alongside regional partners to advocate for continued federal investment and highlight the area’s unique strengths in biotechnology, animal health, and advanced manufacturing.

House Passes DeGette’s Bill Boosting Down Syndrome Research

Source: United States House of Representatives – Congresswoman Diana DeGette (First District of Colorado)

Bipartisan bill improves research and understanding of Down syndrome and co-occurring conditions

WASHINGTON, D.C. — Today, the U.S. House of Representatives passed H.R. 3491, the DeOndra Dixon INCLUDE Project Act, which would advance innovative research into Down syndrome. Representative Diana DeGette (CO-01), who led the bill, along with Representatives Richard Hudson (NC-09), Rosa DeLauro (CT-03), Tom Cole (OK-04), and Pete Stauber (MN-08) released the following statement:

“Today’s passage of the INCLUDE Project Act shows what we can achieve when we make Down syndrome research a true bipartisan priority,” said DeGette. “By advancing this critical legislation, we are showing our commitment to improving health outcomes for individuals with Down syndrome. Colorado is already leading the way as home to the Global Down Syndrome Foundation and their affiliate, the Linda Crnic Institute—the largest institute for Down syndrome research in the world. When this bill becomes law, we will be doubling down on our commitment to groundbreaking science and to the Down syndrome community.”

“People with Down syndrome enrich our families and communities in so many ways,” said Hudson. “I’m proud the House passed my bill to support research that can help them live longer, healthier lives and reach their full potential without barriers standing in their way.”

“Biomedical research is essential,” said DeLauro. “We must do all we can to strengthen the resources that lead to lifesaving medical breakthroughs and help folks with Down syndrome live long, fulfilling lives. Since 2018, as the Ranking Member of the Labor, Health and Human Services Appropriations Subcommittee, I am proud to have worked on a bipartisan basis to provide more than $400 million in funding for the more than 200 INCLUDE Project research grant awards at the National Institutes of Health. We must fight to protect that funding, and this legislation is a needed step to ensure there are no barriers to this important research.”

“Advanced medical research has the potential to change lives – and the DeOndra Dixon INCLUDE Project Act will do just that. Specifically, this legislation will strengthen the collaboration among institutes at the NIH, advance medical breakthroughs, and support Americans with down syndrome,” said Cole. “I’d like to thank Representative DeGette for taking the lead on this legislation, as we must do all we can to improve the lives of those with down syndrome.”

“As a father of a son with Down syndrome, I understand the important role research plays in improving the lives of those with disabilities,” said Stauber. “I’m proud to help lead this effort to ensure continued investment in these life-changing discoveries. Every individual deserves a chance to thrive, and this legislation brings us one step closer to that goal.”

“I have known Diana for 30 years, and throughout that time I have witnessed her extraordinary tenacity, bipartisan leadership, and ability to turn ambitious ideas into consequential legislation, and today’s unanimous House passage of the DeOndra Dixon INCLUDE Project Act adds to her legacy,” said Michelle Sie Whitten, CEO & Co-founder of the Global Down Syndrome Foundation.  “GLOBAL’s advocacy, along with our allies in Congress, helped catalyze the NIH INCLUDE Project into existence as the first NIH-wide Down syndrome research program, and it is already transforming the field—driving important breakthroughs in inflammation and immune system dysregulation, Alzheimer’s disease, sleep apnea, hearing loss, cancer, and more. We are enormously grateful to Diana and her Republican lead partner, Congressman Richard Hudson, for bringing both sides of the aisle together and moving the bill one step closer to becoming law.  Diana’s leadership sends a powerful message: people with Down syndrome matter, their health matters, and their futures are worth fighting for.”

“NDSC strongly supports the INCLUDE Act and applauds the bipartisan leadership behind this important legislation,” said Jim Hudson, National Down Syndrome Congress (NDSC) Executive Director. “Continued investment in Down syndrome research is essential to improving health outcomes, expanding our understanding of co-occurring conditions, and enhancing quality of life for people with Down syndrome across the lifespan.”

The DeOndra Dixon INCLUDE Project Act formally authorizes the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project, which was launched in June 2018 at the direction of Congress to conduct research on critical health and quality-of-life needs for individuals with Down syndrome. The project investigates conditions that affect individuals with Down syndrome and the general population, such as Alzheimer’s disease and dementia, autism, cataracts, celiac disease, congenital heart disease, and diabetes.

The bill would expand clinical trials, investigate biomedical mechanisms of trisomy 21, and address the high prevalence of co-occurring conditions like Alzheimer’s and autoimmune diseases in this population.

###

Congressman Johnson Introduces Historic Bill To Prevent Judges, Justices From Trading Stocks

Source: United States House of Representatives – Representative Hank Johnson (GA-04)

Johnson leads House effort requiring judges and justices to place financial assets into blind trusts

WASHINGTON, D.C. — Today, Congressman Hank Johnson (GA-04) introduced The Justice is BLIND Act, which would prevent judicial conflicts of interest by requiring federal judges and Supreme Court justices to place their financial assets into blind trusts. 

Under this bill, all federal judges, Supreme Court justices, magistrate judges, and bankruptcy judges, as well as their spouses and dependent children, must place covered financial interests into a qualified blind trust within 90 days of enactment or being sworn into office. Judges must provide a written compliance attestation within 15 days of establishing the trust, which the Administrative Office of the United States Courts will publish on a searchable public database.  

In the Senate, this legislation is led by Sen. Adam Schiff (D-CA) and is co-sponsored by Senator Richard Blumenthal (D-Conn.). In the House, the bill is cosponsored by Reps. Sydney Kamlager-Dove (CA-37), Dan Goldman (NY-10), Eleanor Holmes Norton (DC), and Delia C. Ramirez (IL-03).

“Transparency and accountability are at the heart of the public’s trust in government,” said Rep. Johnson, Ranking Member of the Judiciary Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet. “Americans deserve to know that officials in every branch of government — including the judiciary — are acting honorably and in the interest of the people, not their bank accounts. The Justice is BLIND Act would go a long way in preventing any conflicts of interest that might arise and help restore trust in our judiciary by requiring judges and justices to place their financial assets in blind trusts.” 

“The federal judicial system is desperately in need of reform to prevent further ethical lapses. The Supreme Court, and our federal judiciary at large, must be held to the highest standards, but time after time, judges have engaged in troubling acts, putting personal interests above the law and Constitution. I have long called for necessary reforms to regain trust in our system. We must hold judges to the same ethical standards as other federal officials, enhance transparency within the court system, and ensure cases are decided based on merit, not profits. Americans deserve nothing less,” said Senator Schiff.

In the wake of an unprecedented Supreme Court term defined by historic rollbacks  of the Voting Rights Act and other democratic guardrails, Johnson is supporting a legislative package that includes bills to restore faith in the federal judiciary and address abuses of power, including by Supreme Court Justices. The bills would apply conflict of interest ethical standards to federal judges and Justices, and require judges and Justices to place financial assets into blind trusts.

Background: 

A steady stream of alarming revelations in recent years has severely undermined public faith in the independence and integrity of the federal judiciary, including the U.S. Supreme Court. Investigative reports have uncovered a pervasive culture of undisclosed luxury gifts and glaring conflicts of interest, all while Justices refuse to recuse themselves from major cases tied directly to their benefactors’ financial or political advantage.  

 To regain the American people’s trust in our courts, Congress must pass rigorous, binding statutory guardrails that ensure no federal judge can operate above the ethical standards expected of other public servants.

Read The Justice is BLIND Acthere

Ranking member Johnson’s slate of court reform legislation include: The Judiciary Act: Expands SCOTUS to make it more responsive to our growing country; The Supreme Court Ethics Act: Requires justices follow a binding code of ethics; The Judicial Accountability Act: Requires courts to protect their employees from workplace harassment; The 21st Century Courts Act: Enhances accountability & transparency of the federal judiciary by instituting a comprehensive suite of reforms & modernizes our courts for the 21st century; District Court Judgeships Act: Alleviates case backlog by creating 203 new district court judgeships; AMICUS Act: Brings transparency to amicus-based judicial lobbying for the first time; Open Courts Act: Modernizes the federal judiciary’s court records system (called CM/ECF) & makes court records freely available to the public (PACER); The Supreme Court Ethics, Recusal, and Transparency (SCERT) Act: Requires justices of the Supreme Court to adopt and follow a code of ethics, places transparency standards on gifts and travel, codifies recusal standards and requires the court to disclose lobbying and dark money interests before it; The Supreme Court Tenure Establishment and Retirement Modernization (TERM) Act: Would establish term limits for Supreme Court justices while preserving constitutional protections for judicial independence in decision making.

###

House Passes Pallone Legislation to Reauthorize National Traumatic Brain Injury Programs, Honoring Pascrell’s Legacy 

Source: United States House of Representatives – Congressman Frank Pallone (6th District of New Jersey)

Pallone’s legislation renames the nation’s traumatic brain injury program after former New Jersey Congressman Bill Pascrell, Jr. and reauthorizes critical TBI programs through 2030

Washington, D.C. — The House of Representatives today unanimously passed bipartisan legislation introduced by Congressman Frank Pallone, Jr. (NJ-06) to reauthorize the nation’s traumatic brain injury (TBI) programs through 2030 while renaming the federal government’s national TBI surveillance program in honor of former New Jersey Congressman Bill Pascrell, Jr.

The designation recognizes Pascrell’s extraordinary leadership on traumatic brain injury, an issue he championed after meeting Clifton resident Dennis Benigno, whose teenage son suffered a life-altering brain injury in a car crash. Inspired by the family’s experience, Pascrell founded the Congressional Brain Injury Task Force and spent more than two decades leading the fight for brain injury research, prevention, and support services.”

“Naming the nation’s traumatic brain injury program in Bill Pascrell’s honor is a meaningful tribute to my dear friend, who believed people living with traumatic brain injuries deserved a voice in the Congress,” Pallone said. “His ceaseless advocacy transformed how our country understands these injuries and improved the lives of numerous survivors and their families.”

“Today’s vote is an important victory for Americans living with traumatic brain injuries and for the families who stand beside them every day,” said Congresswoman Nellie Pou (NJ-09). “I am proud the House came together to renew these vital programs while honoring the extraordinary legacy of Congressman Bill Pascrell, Jr., whose decades of leadership helped make traumatic brain injury a national priority for the first time. I thank Congressman Frank Pallone for his leadership in advancing this bipartisan bill, and I will keep working with my colleagues to ensure it reaches the President’s desk and becomes law.”

The legislation also reauthorizes three federal programs that support traumatic brain injury research, surveillance, prevention, rehabilitation, and patient advocacy after their authorization expired in 2024.

Originally enacted in 1996, the Traumatic Brain Injury Act established the nation’s first coordinated federal effort to better understand brain injuries. Today, those programs help track the incidence of TBI nationwide, identify populations at greatest risk, improve prevention strategies, support rehabilitation services, and protect the rights of Americans living with brain injuries.

The bill now heads to the Senate.

###

Hoyer, Governor Moore Tour Francis Scott Key Bridge Progress

Source: United States House of Representatives – Congressman Steny H Hoyer (MD-05)

WASHINGTON, DC Today, Congressman Steny H. Hoyer (MD-05) joined Governor Wes Moore to tour the progress being made on the Francis Scott Key Bridge rebuild with Members of the Maryland Congressional Delegation and other congressional leaders to highlight the critical importance of the bridge both to the state and to the entire nation. They were joined by Chair of the Senate Environment and Public Works Committee U.S. Senator Shelley Moore Capito (R-WV) and Chair of the House Appropriations Transportation, Housing and Urban Development Subcommittee U.S. Representative Steve Womack (AR-03), as well as U.S. Senator Angela Alsobrooks (D-MD), U.S. Representatives Kweisi Mfume (MD-07), Johnny Olszewski (MD-02), Glenn Ivey (MD-04), and Former U.S. Senator Ben Cardin (D-MD).

“From day one, Team Maryland has worked together closely to ensure that the Key Bridge is rebuilt as safely, quickly, and cost-effectively as possible,” said Congressman Steny Hoyer (MD-05). “I thank Governor Moore and my colleagues for their efforts to ensure proper Congressional oversight for this critical project for Maryland and the nation.”

“The Francis Scott Key Bridge was a vital economic engine and our commitment to rebuilding it is crucial to the continued prosperity of our nation,” said Governor Moore. “Together with our federal and regional partners, we will rebuild this bridge as quickly, safely, and cost efficiently as possible to ensure that this vital corridor bounces back stronger for generations to come.”

“I am grateful to Governor Moore and his administration for their transparency about the rebuilding of the Francis Scott Key Bridge and for inviting me to tour the site in-person today,” said Chair of the Senate Environment and Public Works Committee Senator Shelley Moore Capito (R-WV). “As Chairman of the Senate Environment and Public Works Committee, I look forward to continuing to partner with Governor Moore and the U.S. Department of Transportation to ensure that congressional funding is used effectively to reopen this critical pathway for people and goods across the region.”

“Proper oversight of the American taxpayer dollars being used to rebuild the Francis Scott Key Bridge is a responsibility I do not take lightly,” said Chair of the House Appropriations Transportation, Housing and Urban Development Subcommittee U.S. Representative Steve Womack (AR-03). “This bridge is a vital artery for the movement of people and goods, and its success unlocks the full potential of commerce along our Eastern seaboard. As Chair of the House Appropriations Transportation, Housing and Urban Development Subcommittee, I am committed to working with President Trump, Transportation Secretary Sean Duffy, and Maryland Governor Wes Moore to ensure this project receives the necessary resources for a safe and efficient rebuild that will prevent a future catastrophe.”

“We’ve always known Team Maryland will fight to rebuild our Francis Scott Key Bridge, and we won’t rest until it’s done. We won’t rest because we’re doing it for all of Maryland: the six Marylanders that lost their lives that day, the brave Marylanders that dove into the frigid water during the rescue operation, and the strong Marylanders whose businesses and livelihoods were impacted by the collapse,” said U.S. Senator Angela Alsobrooks (D-MD). “We’re also doing it for our regional and national economy and everyone who depends upon the Port of Baltimore, which supports our national agriculture and auto industries among many others. It is so exciting to see construction actively underway today. This project highlights what strong federal partnership can accomplish as we remain focused on ensuring taxpayer dollars are spent responsibly while delivering a safe, sustainable bridge.”

“The rebuilding of the Francis Scott Key Bridge represents what can be accomplished when leaders at every level of government come together with a shared purpose,” said U.S. Representative Kweisi Mfume (MD-07). “I am thankful for Governor Moore’s partnership and the unwavering commitment of our federal delegation to restore this critical transportation corridor as safely and as quickly as possible. This project is about restoring economic opportunity, strengthening our supply chain, and reaffirming our commitment to the workers, families, businesses, and communities that depend on the Port of Baltimore. Together, we are delivering on our promise to rebuild stronger than before.”

“Today’s tour underscored what we’ve known from the beginning: rebuilding the Key Bridge is not just a Maryland priority — it’s a national and bipartisan imperative,” said U.S. Representative Johnny Olszewski (MD-02). “We have to keep the momentum going and do everything possible to rebuild it as quickly, safely and cost-effectively as we can.”

“The progress being made on the Francis Scott Key Bridge is a testament to what can be accomplished when federal, state, and local partners work together,” said U.S. Representative Glenn Ivey (MD-04). “As Congress continues to support this effort, we have a responsibility to work with Governor Moore to ensure taxpayer dollars are invested wisely and that this project moves forward safely, efficiently, and without delay. I look forward to continuing our partnership to rebuild this bridge and restore the critical connection that supports Maryland families, businesses, the Port of Baltimore, and our nation’s economy.”

“Thanks to Governor Moore’s leadership, Maryland is working around the clock to rebuild the Key Bridge,” said Maryland Transportation Secretary Katie Thomson. “We appreciated the opportunity to show our congressional partners the significant progress our teams are making as we continue to work together on this nationally significant project.”

“It was a pleasure to show our federal partners the ongoing construction of the bridge as we serve as good stewards of both federal funding and the settlement secured by the State through Attorney General Anthony Brown,” said Maryland Transportation Authority Executive Director Bruce Gartner. “The tour highlighted the tremendous scale of work underway across the Key Bridge Rebuild project, and our crews are making strong progress as we work to safely and efficiently reconnect our communities.”

The Francis Scott Key Bridge was a vital economic and transportation artery for the region, connecting thousands of Maryland commuters and commercial vehicles daily. Its critical function supported the Port of Baltimore, which generates an annual economic impact of more than $70 billion and links more than 273,000 jobs to its activities.

Immediately following the collapse of the bridge, state, local, and federal partners worked tirelessly to advance recovery operations. In only 78 days, the Unified Command removed more than 50,000 tons of debris from the Patapsco River to restore the Fort McHenry Federal Channel, welcoming back global shipping businesses and cruises and getting Marylanders back to work.

The recovery mission included the distribution of more than $42 million in emergency funding from State agencies to keep impacted businesses open and support affected workers in surrounding communities. The rapid response to the crisis—driven by more than 1,500 people from federal, state, and local agencies—allowed the rebuilding to start quickly, while jumpstarting the Port of Baltimore’s recovery.

Pre-construction activities for the rebuild began in January 2025, including detailed engineering tests that provided vital data points to inform design and construction decisions. The project’s test pile program—a critical process to ensure a sound foundation design—began in the fall of 2025 and reached completion ahead of schedule last month. January of this year marked the beginning of platform construction, which will allow supplies, construction personnel, and equipment to reach the pier sites more efficiently to accelerate the construction process.